Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
A recent study found that stability of chromatin structures across DNA replication requires cooperation between a histone chaperone and DNA replication machinery; a mechanism of epigenetic inheritance.
Leon Platanias steers the Lurie Cancer Center toward better patient outcomes. Read the story in Northwestern Medicine magazine.
Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.